Long-term survival and symptomatic relief in lower lobe lung volume reduction surgery
- PMID: 28950329
- DOI: 10.1093/ejcts/ezx242
Long-term survival and symptomatic relief in lower lobe lung volume reduction surgery
Abstract
Objectives: Lung volume reduction surgery (LVRS) has been demonstrated to provide symptomatic relief and improve lung function in patients with end-stage emphysema. The National Emphysema Treatment Trial specifically noted functional benefits in patients with predominantly upper lobe emphysema and demonstrated improvement in quality-of-life parameters, in patients with non-upper lobe emphysema and a low-baseline exercise capacity. We aimed to investigate whether physiological and health status benefits correlated with lower lobe LVRS.
Methods: A retrospective analysis was performed from our prospectively collected patient database. A total of 36 patients with severe, non-upper lobe predominant emphysema underwent lower lobe LVRS in our institution, over a 20-year period. The assessments consisted of measurements of body mass index, pulmonary function tests and health-related quality of life using the Short Form 36-item questionnaires.
Results: Forced expiratory volume in 1 s was seen to improve 3 months [coefficient of time = 1.55 (0.88, 2.21); P < 0.0001] after the procedure, maintained until the first 6 months [0.48 (0.12, 0.85); P = 0.010], decline over the second half of the first year and gradually return to preoperative levels after 2 years, while residual volume to total lung capacity (%) ratio was seen to follow a similar pattern with significant decrease from baseline after 3 months [coefficient of time = -1.76 (-2.75, -0.76); P = 0.001] and 6 months [-1.05 (-1.51, -0.59); P < 0.0001]. Quality-of-life improvements were mainly noted in physical components.
Conclusions: Contrary to a widely held misconception following the National Emphysema Treatment Trial that lower lobe lung volume reduction does not offer significant benefits to patients with non-upper lobe predominant emphysema, we feel justified in offering lower lobe LVRS in these patients when they meet the same selection criteria as upper lobe LVRS.
Keywords: Emphysema; LVRS; Lower lobe; Lung volume reduction surgery; NETT; Thoracic surgery.
© The Author 2017. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.
Similar articles
-
Is lung volume reduction surgery effective in the treatment of advanced emphysema?Interact Cardiovasc Thorac Surg. 2011 Mar;12(3):480-6. doi: 10.1510/icvts.2010.252213. Epub 2010 Dec 5. Interact Cardiovasc Thorac Surg. 2011. PMID: 21131683 Review.
-
The safety, efficacy, and durability of lung-volume reduction surgery: A 10-year experience.J Thorac Cardiovasc Surg. 2016 Mar;151(3):717-724.e1. doi: 10.1016/j.jtcvs.2015.10.095. Epub 2015 Oct 30. J Thorac Cardiovasc Surg. 2016. PMID: 26670190
-
Long-term follow-up of patients receiving lung-volume-reduction surgery versus medical therapy for severe emphysema by the National Emphysema Treatment Trial Research Group.Ann Thorac Surg. 2006 Aug;82(2):431-43. doi: 10.1016/j.athoracsur.2006.05.069. Ann Thorac Surg. 2006. PMID: 16888872 Clinical Trial.
-
Surgical therapy for chronic obstructive pulmonary disease.Semin Respir Crit Care Med. 2005 Apr;26(2):167-91. doi: 10.1055/s-2005-869537. Semin Respir Crit Care Med. 2005. PMID: 16088435 Review.
-
National Emphysema Treatment Trial redux: accentuating the positive.J Thorac Cardiovasc Surg. 2010 Sep;140(3):564-72. doi: 10.1016/j.jtcvs.2010.03.050. J Thorac Cardiovasc Surg. 2010. PMID: 20723727
Cited by
-
Lower lobe lung volume reduction surgery: a case report.Oxf Med Case Reports. 2020 Sep 22;2020(9):omaa067. doi: 10.1093/omcr/omaa067. eCollection 2020 Sep. Oxf Med Case Reports. 2020. PMID: 32995023 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources